Search

Quinn Capers IV, M.D., a nationally recognized leader on diversity and inclusion in academic medicine, has joined UT Southwestern as associate dean for faculty diversity.

When used to manage infections, the drug itraconazole is generally given at a single, fixed dose to all patients.

As more DFW businesses and schools have reopened, and as cases have begun to surge again, researchers are expanding participation for the DFW COVID-19 Prevalence Study – uniquely designed to reveal how widely COVID-19 has spread and why some communities are harder hit.

Administering neuropsychology evaluations to children online in the comfort of their own homes is feasible and delivers results comparable to tests traditionally performed in a clinic, a new study led by UT Southwestern researchers and Children’s Health indicates.

A mutation in the gene that causes cystic fibrosis may accelerate heart function decline in those with Duchenne muscular dystrophy (DMD), a new study by UT Southwestern researchers suggests.

The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased.

Katie Sturm had nearly gotten over the shock of learning she was pregnant with quadruplets when in February she suffered a seizure at work. She was diagnosed with a brain tumor, which was removed at UT Southwestern in March.

Interstitial pneumonia with autoimmune features (IPAF) is a disease with many possible causes and no standard of care, making it particularly difficult to treat. While immunosuppressant drugs are primarily prescribed, they don’t work for all patients.

Oxygen-deprived newborns who undergo cooling therapy to protect their brains are at an elevated risk of seizures and brain damage during the rewarming period, which could be a precursor of disability or death

The Harold C. Simmons Comprehensive Cancer Center has been awarded grants from the Cancer Prevention and Research Institute of Texas to increase minority participation in clinical trials, expand lung cancer screening, develop brain tumor drugs, and advance innovations in drug discovery and technology.